Genmab

board

Company

select Filter
All
Business
Culture
Environment
Health
Politics
Research

Key facts

Latest news (see all)

Genmab to Boost Oncology Portfolio With ProfoundBio Buy

Read: The Wall Street Journal

2024-04-03

Metrics

Business

assets 3.3B $
Debt 56.1M $
free cash flow 126,450,000.00
market cap 23,183,700,000.00
profits 405.8M $

Visualizations

Datasets

Source

Twitter, YAHOO-FIN, YFINANCE

Updated: 3 days ago

License

CC BY 4.0

dark About